Peripheral Neuropathic Pain Completed Phase 1 Trials for Lidocaine (DB00281)

Also known as: Neuralgia / Neuralgia NOS

IndicationStatusPhase
DBCOND0049106 (Peripheral Neuropathic Pain)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01240148Determine the Effect of AZD3161,Injected Intradermally, on Quantitative Sensory Testing Variables in Normal and Ultraviolet-C (UVC) Exposed Skin in Healthy VolunteersBasic Science